甲状腺疾病患者血清可溶性白细胞介素2受体测定的临床意义

某些甲状腺疾病时血清可溶性白细胞介素２受体（ｓＩＬ－２Ｒ）水平及其与游离甲状腺素（ＦＴ＿４）、游离三碘甲腺原氨酸（ＦＴ＿３）和促甲状腺素（ＴＳＨ）水平的相关性比较。结果发现甲状腺机能亢进症（甲亢）未治疗组（Ａ）及甲亢未治疗伴突眼组（Ｄ）血清ｓＩＬ－２Ｒ明显升高；甲状腺机能减退症（甲减）经治疗甲状腺功能灭常组（Ｇ）ｓＩＬ－２Ｒ明显高于甲减未治疗组（Ｆ）；１０例毒性弥漫性甲状腺肿（Ｇｒａｖｅｓ病）患者经抗甲状腺药物治疗后ｓＩＬ－２Ｒ明显降低；Ｇｒａｖｅｓ病及甲减患者血清ｓＩＬ－２Ｒ均与ＦＴ＿３呈正相关。提示除自身免疫外，甲状腺素水平也是甲状腺疾病患者血清ｓＩＬ－２Ｒ水平的重要调节因素。     

我国河南汉族正常人群凝血因子VII基因MspⅠ多态性观察

目的 研究我国汉族正常人群凝血因子Vll基因MspI多态性的分布特点.方法 利用聚合酶链反应-限制性内切酶片段长度多态性(PCR-RFLP)技术,分析560名河南汉族正常人群凝血因子VII(FVII)基因R353Q突变的分布情况.结果 我国河南汉族正常人群FVII基因R353Q的RR,RQ,QQ,基因型频率分别是0.864,0.132,0.004;R,Q等位基因频率分别是0.930,0.070;与国外其他种族相比,基因型及等位基因频率与日本人差异无统计学意义(χ2=2.475,P＞0.05χ2=0.000,P＞0.05);RQ及QQ基因型明显低于意大利人,差异具有统计学意义(χ2=38.536,P＜0.01;χ2=16.311,P＜0.01);Q等位基因明显低于意大利人,差异具有统计学意义(χ2=50.228,P＜0.01).结论 我国河南汉族正常人群FVII基因R353Q突变的基因型分布不同于国外其它种族,具有种族或地域的差异.     

表皮生长因子影响肿瘤患者舌苔变化的分子机制研究

目的 研究表皮生长因子（EGF）对食管癌细胞Eca-109细胞周期及表皮生长因子受体（EGF－R）表达的影响，探讨EGF促进肿瘤患者舌苔增厚的分子机制。方法 应用流式细胞术，检测EGF－R的表达和细胞周期。结果 EGF能明显促进Eca-109细胞膜上EGF－R的表达，使细胞增殖活性大大增强。结论EGF有是通过促进EGF－R的表达影响舌苔形成。     

sIL－2R与SLE的临床表现和自身抗体的相关性

用双抗体夹心ＥＬＩＳＡ检测６６例ＳＩＥ病人血清叽ｓＩＬ－２Ｒ水平，ＳＬＥ病人显著高于正常人，疾病活动期高于非活动期。血清ｓＩＬ－２Ｒ水平与ＡＮＡ、抗ｄｓ－ＤＮＡ抗体、抗Ｓｍ、ＳＳ－Ａ、ＳＳ－Ｂ抗体无关，而与ＳＬＥ患者的发热、贫血、白细胞减少、关节受累及肾脏损害相关，且与ＳＬＥ疾病活动性和ＥＳＲ成正相关，与补体Ｃ＿３、Ｃ＿４和ＣＨ＿（５０）成负相关。提示血清ｓＩＬ－２Ｒ水平是监测ＳＬＥ疾病活动性的一个良好指标。     

不同患者手术前后血中IL-2/sIL-2R系统的动态变化

本文研究28例胆囊炎胆石症、结肠癌和直肠癌患者手术前后血中IL-2/sIL-2R系统的动态变化。分别于手术前或当晨,术后1、2～3、5～7d抽血,测定血中IL-2、sIL-2R量,同时作CRP试验。结果表明,施行中等手术胆囊摘除总胆管切开引流术和半结肠切除术对IL-2/sIL-2R系统的影响与患者术前的水平有关。原先异常程度或轻或重,术后影响亦或轻或重,但均未见统计学差异。3例直肠癌患者施行miles氏手术,术后出现明显IL-2量下降,sIL-2R量增高,持续时间长。因此,初步说明创伤大的手术在一定程度上影响机体的IL-2/sIL-2R系统。并可从中发现规律,采取措施,具有一定的临床价值。     

Anti-AT1R autoantibodies and prediction of the severity of Covid-19

The stimulation of AT1R (Angiotensin II Receptor Type 1) by Angiotensin II has, in addition to the effects on the renin-angiotensin system, also pro-inflammatory effects through stimulation of ADAM17 and subsequent production of INF-gamma and Interleukin-6. This pro-inflammatory action stimulate the cytokine storm that characterizes the most severe forms of SARS-CoV-2 infection. We studied the effect of AT1Rab on the AT1R on 74 subjects with SARS-CoV-2 infection with respiratory symptoms requiring hospitalization. We divided the patients into 2 groups: 34 with moderate and 40 with severe symptoms that required ICU admission. Hospitalized subjects showed a 50% reduction in the frequency of AT1Rab compared to healthy reference population. Of the ICU patients, 33/40 (82.5%) were AT1Rab negative and 16/33 of them (48.5%) died. All 7 patients positive for AT1Rab survived. These preliminary data seem to indicate a protective role played by AT1R autoantibodies on inflammatory activation in SARS-CoV-2 infection pathology.     

Egg allergy, influenza vaccine, and immunoglobulin E antibody.

In a study of 70 patients with asthma, rhinitis, and eczema, those giving a definite history of allergic reactions to egg more frequently showed positive skin tests to egg extracts (p = less than 0.003), the wheal diameters of which were significantly larger (p = less than 0.01) than in patients with only a possible or no such history. Patients with a definite history of egg allergy had significantly higher levels of specific IgE antibody against egg yolk, egg white, and allantoic fluid than patients in the other two groups (p = less than 0.005). Seven patients, all of whom had given a definite history of allergy to egg, were found to have positive skin prick tests to influenza vaccine, at the concentration used in medical practice. Two of these patients had previously been given influenza vaccine and both had developed adverse reactions. Of the 22 patients giving a definite history of allergy to egg, the 7 (35 per cent) with positive skin tests to influenza vaccine had significantly larger skin tests and higher levels of specific IgE antibody to the egg extracts than the group as a whole (p = less than 0.001). Allergic reactions to influenza vaccine are likely to occur in patients who have a definite history of allergy to egg and large skin prick test reactions or high levels of specific IgE antibody to egg extracts. Those at risk can best be identified by skin prick testing with egg extracts and undiluted influenza vaccine.     

雷公藤单体T_4体外给药对IL－2R表达的影响

Ｔ_Ⅱ是中草药雷公藤的一类粗提物，临床治疗类风湿关节炎和系统性红斑狼疮等免疫性疾病效果显著。Ｔ_４是进一步从Ｔ_Ⅱ中提取出的单体成分。以正常人外周血单个核细胞（ＰＢＭＣ）为实验材料，测定了不同浓度的Ｔ_Ⅱ（０．０９８～３．１３Ｕ／ｍｌ）和Ｔ_４（０．０３９～５ｎｇ／ｍｌ）对于Ｔ细胞功能的影响。结果表明，Ｔ_Ⅱ和Ｔ_４对Ｔ细胞表面ＩＬ－２Ｒ的表达剂量相关的抑制作用。结果还显示，在药物作用下，ＩＬ－２对ＩＬ－２Ｒ表达的调节作用是很有限的。     

原发性脑瘤的分子遗传学研究进展

［摘要］ 原发性脑瘤是发生于神经系统常见的疾病，高度恶性的胶质瘤占原发性脑瘤的40%，主要分为I型胶质母细胞瘤（继发性胶质母细胞瘤）和II型胶质母细胞瘤（原发性胶质母细胞瘤），二者的产生有着不同的遗传学改变。I型胶质母细胞瘤的产生途径是从一种恶性程度较低的星形细胞瘤（II级，主要为p53基因突变和血小板来源的生长因子/受体过表达）至恶性的间变型星型细胞瘤（III级，主要为Rb基因突变，CDK4基因扩增，9p、11p、13q和19q的等位基因缺失），再到胶质母细胞瘤（IV级，最常见的遗传学改变是7号和20号染色体的获得,10号染色体的丢失以及PTEN和LRRC4基因的缺失，PDGFα及其受体的过表达）的渐进的发展过程；而II型胶质母细胞瘤则是一种没有恶性程度渐进过程的原发性胶质母细胞瘤，表皮生长因子受体基因的扩增是最常见的遗传学改变。